Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 2845 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 2937 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 3651 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 4120 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 4533 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 4674 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5268 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5281 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5355 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5553 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5882 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5913 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 5977 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6196 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6563 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6598 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6616 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6663 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6759 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6834 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 6925 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7039 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7063 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7132 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7150 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7187 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7498 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7676 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7751 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7834 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7846 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7849 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7903 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 7984 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8020 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8158 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8241 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8541 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8562 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8600 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 8996 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9011 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9013 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9035 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9146 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9329 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9330 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9446 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9678 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9769 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 9925 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 10084 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 10418 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 10585 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 10640 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11033 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11129 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11239 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11625 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11634 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11648 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11723 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11775 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 11986 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12038 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12094 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12371 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12701 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12827 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12919 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 12934 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 13198 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 13246 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 13400 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 13962 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 14371 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 14460 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 14957 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 15016 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 15131 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 15170 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 15759 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 16849 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 16941 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 17092 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 17190 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 17809 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 18061 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 18799 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 19208 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 21858 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 22015 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 26056 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 27379 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 28240 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 31135 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 33373 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | 46102 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | GLUCONIC ACID (CAS# 526-95-4); (M-H)- | Peak area | Control | N | Exemestane | White | Baseline | N | N |